Ozempic-Type Drug Fails To Slow Parkinson’s, Study Finds
WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...
Ozempic-like drug fails to treat Parkinson's disease in new study; here's what the scientists said
A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...
Diabetes drug similar to Ozempic showed no benefits for patients with Parkinson’s disease
A drug for treating diabetes similar to popular weight-loss medicines such as Ozempic did not show any benefits for people ...
Ozempic-like jab 'fails' for millions who suffer age-related condition, study finds
A gold-standard University College of London study found a type of weight-loss jab had no benefit in alleviating a condition ...
Daily Mail6d
Ozempic-like jab 'fails' for millions who suffer age-related condition, study finds
The researchers added there were other ongoing trials examining if drugs like semaglutide, the active ingredient in Ozempic and Wegovy, may be able to help with Parkinson's. However, they noted ...
MedPage Today5d
Why Did a GLP-1 Receptor Agonist Fail This Parkinson's Trial?
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.